In vivo and in vitro inhibition of osteosarcoma growth by the pan Bcl-2 inhibitor AT-101
{{output}}
Osteosarcoma (OS) is the most common primary malignant bone tumor and mainly affects children and adolescents. The OS five-year survival rate remains very low. Thus, novel therapeutic protocols for the treatment of OS are needed. Several approaches targeting d... ...
